V. T. Devita, . Jr, S. Hellman, and S. A. Rosenberg, AIDS: Etiology, Diagnosis, Treatment and Prevention, 1997.

S. H. Bridges and N. Sarver, Gene therapy and immune restoration for HIV disease, Lancet, vol.345, pp.427-432, 1995.

M. Rosenzweig, D. F. Marks, D. Hempel, J. Lisziewicz, and R. P. Johnson, Transduction of CD34 + hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection, J. Virol, vol.71, pp.2740-2746, 1997.

T. Nakaya, S. Iwai, K. Fujinaga, Y. Sato, E. Otsuka et al., Decoy approach using RNA/DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 rev protein, Antimicrob. Agents Chemother, vol.41, pp.319-325, 1997.

D. P. Bednarik, J. D. Mosca, N. B. Raj, and P. M. Pitha, Inhibition of human immunodeficiency virus (HIV) replication by HIV-transactivated a 2 -interferon, Proc. Natl Acad. Sci. USA, vol.86, pp.4958-4962, 1989.

H. C. Schro-Èder, R. J. Suhadolnik, W. Pfleiderer, and W. E. Mu-Èller, H -5 H ) Oligoadenylate and intracellular immunity against retrovirus infection, Int. J. Biochem, vol.24, issue.2, pp.55-63, 1992.

T. Shirasaka, M. F. Kavlick, T. Ueno, W. Y. Gao, R. Kojima et al., Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides, Proc. Natl Acad. Sci. USA, vol.92, pp.2392-2402, 1995.

D. Finzi, M. Hermankova, T. Pierson, L. M. Carruth, C. Buck et al., Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy, Science, vol.278, pp.1295-1300, 1997.

S. R. Riddell, M. Elliott, D. A. Lewinsohn, M. J. Gilbert, L. Wilson et al., T-cell mediated rejection of gene-modified HIV-1 specific cytotoxic T lymphocytes in HIV-infected patients, Nat. Med, vol.2, pp.216-223, 1996.

D. Baltimore, Intracellular immunization, Nature, vol.335, pp.7395-7396, 1988.

G. R. Stark, I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber, How cells respond to interferons, Annu. Rev. Biochem, vol.67, pp.227-264, 1998.

M. J. Clemens and A. Elia, The double-stranded RNA-dependent protein kinase PKR: structure and function, J. Interferon Cytokine Res, vol.17, pp.503-523, 1997.

J. W. Hershey, Translational control in mammalian cells, Annu. Rev. Biochem, vol.60, pp.717-755, 1991.

J. Galabru and A. G. Hovanessian, Autophosphorylation of the protein kinase dependent upon double-stranded RNA, J. Biol. Chem, vol.262, pp.15538-15544, 1987.

C. G. Proud, PKR: a new name and new roles, Trends Biochem. Sci, vol.20, pp.241-246, 1995.

A. Kumar, J. Haque, J. Lacoste, J. Hiscott, and B. R. Williams, Double-stranded RNA-dependent protein kinase activates transcription factor NF-kB by phosphorylating I-kB, Proc. Natl Acad. Sci. USA 91, pp.6288-6292, 1994.

D. Thanos and T. Maniatis, NF-kB: a lesson in family values, Cell, vol.83, pp.1091-1100, 1995.

M. Katze, Games viruses play: a strategic initiative against the interferon-induced dsRNA activated 68,000 M r protein kinase, 1993.

S. C. Sen and R. M. Ransohoff, Interferon-induced antiviral actions and their regulation, Adv. Virus Res, vol.42, pp.57-102, 1993.

S. Roy, M. Katze, N. Parkin, I. Edery, A. Hovanessian et al., Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product, Science, vol.247, pp.1216-1219, 1990.

S. Roy, M. Agy, A. G. Hovanessian, . Sonenberg, and M. G. Katze, The integrity of the stem structure of human immunodeficiency virus type 1 tat-responsive sequence RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase, J. Virol, vol.65, pp.632-640, 1991.

R. Judeware, J. Li, and R. Petryshyn, Inhibition of the dsRNAdependent protein kinase by a peptide derived from the human immunodeficiency vius type 1 tat protein, J. Interferon Res, vol.13, pp.153-160, 1993.

N. A. Mcmillan, R. F. Chun, D. P. Siderovski, J. Galabru, W. M. Toone et al., HIV-1 tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology, vol.213, pp.413-424, 1995.

D. Markowitz, S. Goff, and A. Bank, A safe packaging line for gene transfer: separating viral genes on two separate plasmids, J. Virol, vol.62, pp.1120-1125, 1988.

E. Meurs, K. Chong, J. Galabru, N. S. Thomas, I. M. Kerr et al., Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon, Cell, vol.62, pp.379-390, 1990.

J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning: a Laboratory Manual, 1989.

C. A. Rosen, J. G. Sodroski, and W. A. Haseltine, The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat, Cell, vol.41, pp.813-823, 1985.

F. Sanger, S. Nicklen, and A. R. Coulson, DNA sequencing with chain-terminating inhibitors, Proc. Natl Acad. Sci. USA, vol.74, pp.5463-5467, 1977.

N. Levitt, D. Briggs, A. Gil, and N. J. Proudfoot, Definition of an efficient synthetic poly (A) site, Genes Dev, vol.3, pp.1019-1025, 1989.

A. D. Miller, D. G. Miller, J. V. Garcia, and C. M. Lynch, Use of retroviral vectors for gene transfer and expression, Methods Enzymol, vol.217, pp.581-599, 1993.

R. L. Willey, D. H. Smith, L. A. Lasky, T. S. Theodore, P. L. Earl et al., In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity, J. Virol, vol.62, pp.138-147, 1988.

D. C. Thomis, J. P. Doohan, and C. E. Samuel, Mechanism of interferon action: cDNA structure, expression and regulation of the interferon-induced, RNA dependent P1/eIF-2a protein kinase from human cells, Virology, vol.188, pp.33-46, 1992.

O. Savinova and R. Jagus, Use of vertical slab isoelectric focusing and immunoblotting to evaluate steady-state phosphorylation of eIF2 alpha in cultured cells, Methods, vol.11, pp.419-425, 1997.

E. Schreiber, P. Matthias, M. M. Muller, and W. Schaffner, Rapid detection of octamer binding proteins with`mini-extracts, Nucleic Acids Res, vol.17, p.6419, 1989.

J. Kwon, S. J. Lee, and E. N. Benveniste, A 3 H cis-acting element is involved in tumor necrosis factor-a gene expression in astrocytes, J. Biol. Chem, vol.271, pp.22383-22390, 1996.

M. E. Adelson, Intracellular immunization: Control of human immunodeficiency virus replication through the tat-inducible regulation of the double-stranded RNA dependent protein kinase, 1997.

M. G. Wathelet, I. M. Clauss, F. C. Paillard, and G. A. Huez, 2-Aminopurine selectively blocks the transcriptional activation of cellular genes by virus, double-stranded RNA and interferons in human cells, Eur. J. Biochem, vol.184, pp.503-509, 1989.

D. V. Havlir, I. C. Marschner, M. S. Hirsch, A. C. Collier, P. Tebas et al., Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy, N. Engl. J. Med, vol.339, pp.1261-1268, 1998.

G. Pialoux, F. Raffi, F. Brun-vezinet, V. Meiffredy, P. Flandre et al., A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients, N. Engl. J. Med, vol.339, pp.1269-1276, 1998.

N. F. Muto, M. E. Adelson, C. Martinand, and R. J. Suhadolnik, Inhibition of HIV-1 replication in latently-infected cells through the retroviral delivery of HIV-1 LTR-driven PKR cDNA constructs, Keystone Symposia on Molecular and Cellular Biology, 1999.

R. W. Sobol, E. E. Henderson, N. Kon, J. Shao, P. Hitzges et al., Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/ phosphodiester 2 H ,5 H -oligoadenylate derivatives, J. Biol. Chem, vol.270, pp.5963-5978, 1995.

H. C. Schro-Èder, R. Wenger, Y. Kuchino, and W. E. Muller, Modulation of nuclear matrix-associated 2 H ,5-oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus, J. Biol. Chem, vol.264, pp.5669-5673, 1989.

K. T. Iacono, M. E. Adelson, and R. J. Suhadolnik, Inhibition of HIV-1 replication through the retroviral delivery of the 40 kDa 2 H ,5 H -oligoadenylate synthetase antiviral enzyme, Keystone Symposia on Molecular and Cellular Biology, 1999.